Portugal Patent System

Portugal's energy sector has undergone one of Europe's most dramatic transformations: in 2023, approximately 60% of Portugal's electricity came from renewables (hydro + wind + solar), and in some months Portugal achieved near-100% renewable electricity production for short periods. Key energy companies with patent portfolios: (1) EDP — Energias de Portugal (Lisbon, Euronext Lisbon listed): EDP is one of Europe's largest utilities and a global leader in renewable energy. EDP Renováveis (EDPR, Madrid-listed subsidiary) operates wind farms globally in the US, Europe, and Brazil. EDP's patent activities span: offshore wind installation method patents (cable-laying, monopile/jacket foundation installation); grid integration and smart grid patents (demand response, distribution automation); EDP's research centers: EDP Inovação (Lisbon) and EDP Labelec (Sacavém, near Lisbon) — technical R&D in grid technology, hydropower optimization, smart meters; (2) Galp Energia (Lisbon, Euronext Lisbon listed): Portugal's integrated oil and gas company; Galp's primary patent activities: petroleum refining processes (Matosinhos refinery, Porto area — one of the most modern refineries in the Iberian Peninsula); lubricant formulation patents; biofuel conversion processes (Galp has invested heavily in HVO — Hydrotreated Vegetable Oil — production at its refineries, using recycled cooking oil and crop residues, reducing carbon intensity); Galp has made significant investment in Brazilian pre-salt deepwater oil fields (Santos Basin) through exploration partnerships; offshore Brazil technology patents (drilling optimization, subsea production); solar energy: Galp Solar — residential and commercial solar installation; (3) REN (Redes Energéticas Nacionais, Lisbon — Portugal's electricity and natural gas transmission operator): grid optimization patents, SCADA system patents; (4) Vestas (major installations in Portugal — wind turbines for EDP/EDPR and independent projects); (5) Efacec (Maia, near Porto — electrical equipment, power transformers, EV charging infrastructure): Efacec is the largest Portuguese industrial company in the electrical/electronics sector; patents in power transformer design, traction converters, EV charging station hardware (Efacec supplies EV chargers internationally); (6) Critical Materials (Braga — rare earth element purification for EV motors and defense applications): startup with patents in REE separation processes, targeting NATO and European supply chain sovereignty goals.

Portugal's innovation ecosystem has grown substantially since 2010, fueled by EU structural funds, a large diaspora returning from international careers (particularly from financial centers and tech hubs), and a favorable cost structure for startups: (1) Lisbon tech scene: Lisbon has become a significant European tech hub — home to Web Summit (which relocated from Dublin to Lisbon in 2016 and brings 70,000+ attendees annually) and a growing number of tech unicorns; (2) Farfetch (founded by José Neves, Porto-born): luxury fashion e-commerce platform; Farfetch technology patents in luxury retail personalization, virtual try-on (AR technology), and logistics; listed NYSE before privatization; (3) Talkdesk (Porto/San Francisco — cloud call center/contact center software, CCaaS): founded by Tiago Paiva; patents in cloud telephony, AI-driven customer service routing, NLP for customer intent classification; Portuguese-origin unicorn; (4) Feedzai (Coimbra/San Francisco — ML-based financial fraud detection for banks): founded by Nuno Sebastião; patents in real-time transaction fraud detection, risk scoring algorithms; provides fraud detection for Santander, Standard Chartered, and other major banks; (5) Sword Health (Porto/New York — AI-powered physical therapy, digital musculoskeletal care): patents in motion capture for physical therapy (sensor-based movement analysis), AI-driven exercise prescription, patient progression models; (6) OutSystems (Linda-a-Velha, near Lisbon — low-code/no-code enterprise application development platform): Portuguese tech company with enterprise software patents; (7) Waukeen (Braga — medical device patents in neuromodulation, deep brain stimulation); (8) University tech transfer: Universidade de Lisboa (ULisboa — via Inovação.ULisboa), Universidade do Porto (UP), Universidade de Coimbra (UC), Universidade Nova de Lisboa, Instituto Superior Técnico (IST, Lisbon — electrical engineering, computer science, aerospace engineering — significant EPO filer via Portuguese Science Foundation grants). FCT (Fundação para a Ciência e a Tecnologia) funds R&D and facilitates patent filing. COTEC Portugal (Business Association for Innovation) — industry-university technology transfer; (9) Biomédico (Braga — medical device manufacturing); INAPH (Instituto Nacional de Investigação Agrária e Veterinária — agriculture and food science patents); (10) Viatecla (Porto — IT systems, police/emergency dispatch technology, public safety communications patents).

Portugal's utility model (modelo de utilidade) under the Código da Propriedade Industrial (CPI 2021) provides protection for technical innovations in the shape, configuration, or arrangement of a product (not processes). Key features that distinguish it from a full Portuguese invention patent: (1) 6-year term — notably shorter than most EU utility models (Germany, Austria, Denmark: 10yr; Spain: 10yr) and significantly shorter than an invention patent (20yr). The 6-year utility model is better suited for shorter-lifecycle products; (2) Lower inventive step threshold — the modelo de utilidade requires novelty and industrial applicability, but the inventive step requirement is lower (below the 'non-obvious to a person skilled in the art' standard of an invention patent). The innovation must be novel and useful but does not need to demonstrate the same level of non-obviousness; (3) Products only — the Portuguese utility model explicitly covers the shape, configuration, or arrangement of articles (products, devices, apparatus), and DOES NOT protect processes, methods of manufacture, chemical compounds, or compositions of matter. A new manufacturing process cannot be protected as a utility model; (4) Registered without substantive examination — INPI conducts a prior art search and issues a search report, but does not conduct a full substantive examination of inventive step or novelty. Registration is granted after formal examination, making the process faster (approximately 1–2 years); (5) Strategic use — the modelo de utilidade is used by Portuguese SMEs for product-specific mechanical and structural innovations, where speed matters and cost savings are valuable. It is particularly useful for tools, instruments, apparatus components, and product form innovations. Because there is no substantive examination, validity is easier to challenge in enforcement proceedings; (6) Comparison with Spain — Spain's utility model (modelo de utilidad) has a 10-year term and covers objects/devices only (NOT processes), registered without examination — structurally similar to Portugal but 4 years longer. Both exclude processes.

Portugal is a UPC participating state, meaning that Unitary Patents take automatic effect in Portugal when granted by the EPO, and the Unified Patent Court has jurisdiction over those patents in Portuguese territory. Key aspects: (1) Lisbon UPC Local Division — the Lisbon Local Division of the UPC handles UPC infringement cases where the alleged infringement occurred in Portugal and invalidity counterclaims in those cases. The Lisbon UPC Local Division is staffed by Portuguese judges with UPC specialist training and technical qualified judges for specific technical fields; (2) Unitary Patent coverage — for patent holders seeking pan-European protection via the EPO's Unitary Patent, a single Unitary Patent automatically covers all UPC participating states (including Portugal) without needing separate national validation. This is significantly more cost-effective than separately validating an EP patent in each EPC state; (3) London Agreement advantage — Portugal has joined the London Agreement (reducing EP translation requirements). For EP patents granted in English, French, or German, validation in Portugal requires only a translation of the claims into Portuguese (or in some cases, just an abstract). This reduces the cost of validating EP patents in Portugal compared to countries that have not signed the London Agreement. This London Agreement benefit applies to classical EP validation, while the Unitary Patent for UPC states requires only English (and one other EPO language) — even simpler; (4) Portuguese national patents remain outside UPC — Portuguese national invention patents (filed with INPI) are not subject to UPC jurisdiction. The UPC applies only to EP patents and Unitary Patents; (5) Practical significance — Portugal's pharmaceutical sector (BIAL, Generis, Bluepharma, Tecnimede) and technology companies have an interest in the Lisbon UPC Local Division for both enforcement of their own IP and defending against infringement claims brought by international patent holders in the Portuguese market.

Portugal, as an EPC contracting state since January 1, 1992, follows EPC Article 54's strict absolute novelty standard — there is NO general grace period for Portuguese national patents or for European patents (EP) validated in Portugal. Any public disclosure of the invention before the patent application filing date will destroy novelty and make the invention unpatentable, with only a very narrow exception. The narrow EPC Art. 55 exception applicable in Portugal allows a prior disclosure to be disregarded for novelty purposes only if: (a) the disclosure occurred within 6 months before the Portuguese (or EP) filing date (or before the priority date if claiming priority), AND (b) the disclosure was due to an evident abuse in relation to the applicant or predecessor in title (e.g., industrial espionage/theft), OR (c) the disclosure was at an officially recognized international exhibition under the Convention on International Exhibitions (Paris, November 22, 1928). This exception covers only specific formally recognized world exhibition events — NOT ordinary scientific conferences, academic seminar presentations, scientific journal publications, investor demos, trade fair exhibitions (even major international trade shows), social media posts, YouTube videos, or product launches. A Portuguese researcher or founder who presents their invention at a technology conference in Lisbon, posts about it on LinkedIn, or publishes a paper before filing a patent application will permanently lose Portuguese (and European EPC) patent rights for that invention. Contrast with US law: the US AIA § 102(b)(1) provides a 12-month grace period covering ANY own disclosure of any kind (publications, sales offers, presentations — in any form and anywhere in the world) before the US filing date. Portuguese/EU and US patent strategy: inventors with technology having both US and Portuguese/European patent potential should file the patent application BEFORE any public disclosure. Alternatively: if disclosure has already occurred, US patent rights may still be available (within 12 months of own disclosure), while Portuguese/European patent rights are permanently lost from the moment of disclosure.

Portugal's cork industry IP is unique globally because of the combination of: (1) geographic concentration (Portugal produces approximately 50% of global cork, with the Alentejo region being the world's largest cork oak forest), (2) the biodiversity of cork oak (Quercus suber) ecosystems, and (3) the sophisticated material science that has developed around cork applications. The IP landscape in Portuguese cork: (a) Cork stopper quality patents: Amorim, the world's largest cork company, has developed and patented the ROSA (Rate of Optimal Steam Application) process — which uses supercritical CO2 or steam treatment to remove TCA (2,4,6-trichloroanisole), the compound responsible for cork taint in wine. Cork taint affected a significant percentage of natural cork stoppers historically (estimates range from 2–7%), damaging both the wine industry and the cork industry's reputation. Neutrocork technology addresses this quality problem; (b) Cork composite materials: agglomerated cork (cork granules + natural suberin binders + synthetic binders) for champagne stoppers, flooring (Wicanders brand), wall tiles, and industrial vibration damping. Cork composite formulation patents control the binder chemistry and density/compression behavior; (c) Aerospace applications: Amorim Cork Composites (a division of Amorim) supplies cork-based ablative thermal protection materials to European Space Agency programs — cork is used in ESA Ariane rocket fairings and heat shields because of its low density, thermal insulation, and ablative characteristics under high heat flux. These aerospace applications require specific material specifications not found in wine stoppers; (d) Construction and acoustics: ICB (Insulation Cork Board) is compressed cork granule panels without adhesives, used for thermal insulation and acoustic damping in buildings. Patents cover manufacturing process parameters and specific acoustic/thermal performance levels for building applications; (e) Railway vibration damping: cork composites under railway sleepers reduce ground-borne vibration transmission — used in urban rail systems in Portugal, Spain, and internationally. The ability to protect this unique industrial heritage through patents and trade secrets is commercially significant for Portuguese companies that lead in a globally irreplaceable natural material.

Portugal's patent-active organizations span pharma, energy, cork/materials, and technology: (1) BIAL (Portela, near Porto — pharmaceutical): Portugal's most internationally significant pharma company. Products: eslicarbazepine acetate (Aptiom/Zebinix — anticonvulsant for partial-onset seizures; licensed to Sunovion for US market) and opicapone (Ongentys — COMT inhibitor for Parkinson's disease motor fluctuations; licensed to Neurocrine Biosciences for US). BIAL's patent portfolio covers compound composition + stereoisomers, pharmaceutical formulation, and methods of treatment patents for CNS/neurology indications. BIAL is one of the rare examples of a small-country pharmaceutical company achieving internationally licensed patented breakthrough drugs; (2) Amorim Group (Mozelos, near Porto — cork): world's largest cork company; patents in TCA-removal processes (ROSA/Neutrocork), cork composite formulations, aerospace ablative materials, cork flooring systems; (3) Galp Energia (Lisbon — energy): petroleum refining process patents, HVO biofuel conversion, lubricant formulations, Brazil deepwater exploration technology; (4) EDP/EDPR (Lisbon — renewables): offshore wind installation patents, grid integration, smart meter systems; (5) Efacec (Maia — electrical equipment): power transformer patents, EV charging hardware, traction converters; (6) Talkdesk (Porto — cloud contact center): cloud telephony, AI customer service routing, NLP patents; (7) Feedzai (Coimbra — fraud detection ML): real-time transaction fraud scoring, behavioral analytics patents; (8) Sword Health (Porto — digital physical therapy): sensor-based motion capture for physical therapy, AI exercise prescription; (9) OutSystems (Linda-a-Velha — low-code): enterprise application development platform patents; (10) Research institutions: Instituto Superior Técnico (IST/ULisboa — Lisbon); Universidade do Porto (UP); Universidade de Coimbra (UC — iMed.CNC, Center for Neuroscience and Cell Biology); University of Minho (Braga — 2C2T [Center for Textile Science and Technology], bioengineering); INESC TEC (Porto — systems engineering/computer science/renewable energy research). FCT (Fundação para a Ciência e a Tecnologia) is the primary research funding agency.